Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15007-15017
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15007
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15007
Tumor classification | Definition | Stage | Criteria |
T0, N0, M0 | No tumor found | ||
T1 | 1 nodule < 2.0 cm | Stage I | T1 lesion |
T2 | 1 nodule 2-5 cm, 2 or 3 nodules each less than 3 cm | Stage II | T2 lesion |
T3 | 1 nodule > 5 cm, 2 or 3 nodules, at least 1 > 3 cm | Stage III | T3 lesion |
T4a | ≥ 4 nodules, any size | Stage IVa1 | T4a |
T4b | T2, T3 or T4a plus gross intrahepatic, portal or hepatic vein involvement as indicated by CT, MRI or US | Stage IVa2 | T4b |
N1 | Regional (porta hepatis) node involvement | Stage IVb | Any N1 or M1 |
M1 | Metastatic disease including extrahepatic portal or hepatic vein involvement |
- Citation: Khan AS, Fowler KJ, Chapman WC. Current surgical treatment strategies for hepatocellular carcinoma in North America. World J Gastroenterol 2014; 20(41): 15007-15017
- URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15007.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i41.15007